Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

Original Submission
5 Oct 2023 Submitted Original manuscript
20 Oct 2023 Reviewed Reviewer Report
29 Oct 2023 Reviewed Reviewer Report - Sabine Matou-Nasri
30 Oct 2023 Reviewed Reviewer Report
1 Nov 2023 Reviewed Reviewer Report
16 Feb 2024 Author responded Author comments - Chun-Nan Yeh
28 Feb 2024 Author responded Author comments - Chun-Nan Yeh
Resubmission - Version 2
16 Feb 2024 Submitted Manuscript version 2
15 May 2024 Author responded Author comments - Chun-Nan Yeh
Resubmission - Version 3
15 May 2024 Submitted Manuscript version 3
19 Jun 2024 Author responded Author comments - Chun-Nan Yeh
Resubmission - Version 4
19 Jun 2024 Submitted Manuscript version 4
25 Jun 2024 Author responded Author comments - Chun-Nan Yeh
Resubmission - Version 5
25 Jun 2024 Submitted Manuscript version 5
Publishing
26 Jun 2024 Editorially accepted
11 Jul 2024 Article published 10.1186/s12885-024-12567-1

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us